Botox

Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
Flag link:
Could synthetic Botox soothe chronic pain? A new study holds out the possibility
Could synthetic Botox soothe chronic pain? A new study holds out the possibility
Stat
Botox
chronic pain
Allergan
Flag link:
FDA stiff arms Evolus’ rival to Allergan’s blockbuster Botox, but execs promise a snap response
FDA stiff arms Evolus’ rival to Allergan’s blockbuster Botox, but execs promise a snap response
Endpoints
Evolus
Allergan
Botox
FDA
DWO-450
Flag link:
Allergan's Botox sets its sights on a new customer: men
Allergan's Botox sets its sights on a new customer: men
Medical Marketing and Media
Allergan
DTC advertising
Botox
Flag link:
Botox Biosimilar in Development by Mylan and Revance Therapeutics
Botox Biosimilar in Development by Mylan and Revance Therapeutics
Xtalks
Botox
Allergan
biosimilars
Mylan Labs
Revance Therapeutics
Flag link:
Mylan teams up with Revance on biosimilar for Botox
Mylan teams up with Revance on biosimilar for Botox
Reuters
Mylan Labs
ReVance
biosimilars
Botox
Flag link:
Will Allergan cannibalize Botox with ubrogepant?
Will Allergan cannibalize Botox with ubrogepant?
Biopharma Dive
Allergan
Botox
ubrogepant
migraines
Flag link:
Evolus says its Botox biosimilar could be delayed by FDA issues with Daewoong plant
Evolus says its Botox biosimilar could be delayed by FDA issues with Daewoong plant
Fierce Pharma
Evolus
Botox
biosimilars
FDA
drug manufacturing
Flag link:
Look out, Allergan: Doctor surveys show the 'Botox competitive threat is real'
Look out, Allergan: Doctor surveys show the 'Botox competitive threat is real'
Fierce Pharma
Allergan
Botox
competition
Evolus
Revance Therapeutics
Hugel
Flag link:
Boasting a late-stage Botox me-too, Evolus files for $75M IPO
Boasting a late-stage Botox me-too, Evolus files for $75M IPO
Endpoints
Evolus
Botox
Allergan
IPOs
DWP-450
biosimilars
Flag link:
Settle down, Allergan investors. Botox's market share is safe, analysts say
Settle down, Allergan investors. Botox's market share is safe, analysts say
Fierce Pharma
Allergan
Botox
wrinkle treatment
ReVance
RT002
Flag link:
Watch out Allergan: Revance’s wrinkle-reducer beats Botox in PhIII trials
Watch out Allergan: Revance’s wrinkle-reducer beats Botox in PhIII trials
Endpoints
Allergan
ReVance
Botox
clinical trials
RT002
wrinkle treatments
Flag link:
3 Big Pharma Stocks Set to Succeed
3 Big Pharma Stocks Set to Succeed
Motley Fool
AbbVie
Humira
patents
Allergan
Botox
Celgene
Revlimid
Flag link:
Allergan moneymaker Botox grabs another cosmetic approval, this time in forehead lines
Allergan moneymaker Botox grabs another cosmetic approval, this time in forehead lines
Fierce Pharma
Allergan
FDA
Botox
Flag link:
Allergan reaches the masses via unbranded Botox Facebook page
Allergan reaches the masses via unbranded Botox Facebook page
Medical Marketing and Media
Allergan
Botox
Facebook
social media
Flag link:
Allergan To Test Botox For Depression Despite Mixed Results
Allergan To Test Botox For Depression Despite Mixed Results
Forbes
Allergan
Botox
clinical depression
clinical trials
Flag link:
Allergan eyes depression as blockbuster Botox's next big stage
Allergan eyes depression as blockbuster Botox's next big stage
Fierce Pharma
Allergan
Botox
clinical depression
Flag link:
Botox: Dead Man Walking
Botox: Dead Man Walking
Seeking Alpha
Botox
Allergan
JNJ
Bovie Medical
Boston Scientific
Medtronic
NuGene
Flag link:
Botox Seems To Ease Depression
Botox Seems To Ease Depression
Forbes
Botox
clinical depression
Allergan
Actavis
Flag link:
U.S. court revives Botox-linked shareholder suit against Allergan
U.S. court revives Botox-linked shareholder suit against Allergan
Yahoo/Reuters
Botox
Allergan
shareholders
Flag link:

Pages